Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-25-014180

Options or other derivatives

  • CEO acquired 0 shares (option exercise)
  • CEO acquired 37,760 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pershing Edward CEO 2025-09-19 Option exercise · 8% Unsecured Convertible Promissory Note −0 D
Pershing Edward CEO 2025-09-19 Option exercise · Series D-1 Convertible Preferred Stock +37,760 2,418,447 D
Loading xslF345X05/ownership.xml…